Tris Pharma

Perrigo and Tris Pharma Launch Store Brand Version of DelsymAllegan-based Perrigo Co. and Tris Pharma Inc. announced the commercial launch of a major new store brand product. The new product is equivalent to Delsym extended-release oral liquid suspension containing dextromethorphan polistirex and will be marketed under major U.S. retailer and wholesalers' store brands or own label brands.
Perrigo Announces FDA Approval Of Generic DelsymPerrigo Co. (Nasdaq: PRGO) announced that the United States Food and Drug Administration has granted final approval to Tris Pharma for its abbreviated new drug application for Dextromethorphan Polistirex Extended-Release Oral Suspension, the store brand equivalent to Reckitt Benckiser's Delsym suspension.